- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03608436
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery (RECOVER)
RECOVER Study: the Effect of Low- Versus Normal Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on the Early Quality of Recovery With Perioperative Care According to the Enhanced Recovery Principles
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: the laparoscopic approach reduced trauma as compared to open surgery, however, the pressure used to create a PNP with sufficient surgical workspace still leads to significant tissue injury. Prior studies show that the use of low-pressure pneumoperitoneum (PNP) during laparoscopic surgery reduced postoperative pain scores, cumulative opioid consumption and improved bowel function recovery. Deep neuromuscular blockade (NMB) as compared to moderate NMB decreases the amount of intra-abdominal pressure required to achieve similar surgical conditions and enables the use of low-pressure PNP without compromising the quality of the surgical field and patient safety. Therefore, the use of deep NMB with low-pressure PNP could be a significant addition to the conventional Enhanced Recovery After Surgery (ERAS) protocols.
Objective: to establish the relationship between the use of low pressure pneumoperitoneum with deep neuromuscular blockade and the early quality of recovery after laparoscopic colorectal surgery.
Study design: a multi-center, blinded, randomized controlled clinical trial.
Study population: adult individuals scheduled for laparoscopic colorectal surgery with a primary colonic anastomosis.
Intervention: participants will be randomly assigned in a 1:1 fashion to either the experimental group (group A): low pressure PNP (8 mmHg) with deep NMB (PTC 1-2) or the control group (group B): normal pressure PNP (12 mmHg) with moderate NMB (TOF count 1-2).
Primary endpoint: Quality of recovery score (QoR-40) 24 hours after surgery.
Secondary endpoints: QoR-40 score (day 3 and 7 after surgery), McGill pain- and RAND-36 score (1 day before and 3 months after surgery), pain scores, PONV, analgesia use, length of hospital stay, postoperative complications, surgical conditions and time to reach discharge criteria.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Groningen, Netherlands
- Martini general hospital
-
Veldhoven, Netherlands
- Máxima Medisch Centrum
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6532SZ
- Canisius Wilhelmina Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Scheduled for laparoscopic colorectal surgery with a primary anastomosis
- Obtained informed consent
- Age over 18 years
Exclusion Criteria:
- Insufficient control of the Dutch language to read the patient information and to fill out the questionnaires
- Primary colostomy
- Neo-adjuvant chemotherapy
- Chronic use of analgesics or psychotropic drugs
- Use of NSAIDs shorter than 5 days before surgery
- Known or suspected allergy to rocuronium of sugammadex
- Neuromuscular disease
- Indication for rapid sequence induction
- Severe liver- or renal disease (creatinine clearance <30ml/min)
- BMI >35 kg/m²
- Deficiency of vitamin K dependent clotting factors or coagulopathy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low pressure PNP, deep NMB
Low pressure pneumoperitoneum of 8 mmHg with deep neuromuscular block (post tetanic count of 1-2) reached by titration with continuous infusion of Rocuronium bromide.
|
Lowering intra-abdominal pressure during laparoscopic surgery
Other Names:
Deep (PTC 1-2) versus moderate (Tof count 1-2) neuromuscular block
Other Names:
|
Active Comparator: Normal pressure PNP, moderate NMB
Normal pressure pneumoperitoneum of 12 mmHg with moderate neuromuscular block (TOF count of 1-2) reached by titration with bolus or continuous infusion of a low dose of Rocuronium bromide.
|
Deep (PTC 1-2) versus moderate (Tof count 1-2) neuromuscular block
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total score on the Quality of Recovery-40 questionnaire
Time Frame: 24 hours after surgery
|
The QoR-40 is a validated assessment tool for measuring a patient's self-assessed quality of recovery after surgery.
It consists of 40 questions measuring 5 dimensions: patient support, comfort, emotions, physical independence and pain.
Each item is rated on a scale of 1 to 5, giving a minimal score of 40 and a maximum score of 200.
|
24 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total score on the Quality of Recovery-40 questionnaire
Time Frame: Day 3 and day 7 after surgery
|
The QoR-40 is a validated assessment tool for measuring a patient's self-assessed quality of recovery after surgery.
It consists of 40 questions measuring 5 dimensions: patient support, comfort, emotions, physical independence and pain.
Each item is rated on a scale of 1 to 5, giving a minimal score of 40 and a maximum score of 200.
|
Day 3 and day 7 after surgery
|
McGill pain Questionnaire
Time Frame: Upon admission and 3 months after surgery
|
Validated questionnaire for the assessment of quality and intensity of pain
|
Upon admission and 3 months after surgery
|
RAND-36 general health questionnaire
Time Frame: Upon admission and 3 months after surgery
|
Validated patient-reported survey of health
|
Upon admission and 3 months after surgery
|
Pain scores
Time Frame: 1, 8, 24, and 72 hours after surgery
|
Pain at rest and pain upon movement (NRS 0-10), is pain acceptable yes or no, referred shoulder pain yes or no?
|
1, 8, 24, and 72 hours after surgery
|
Post-operative nausea and vomiting (PONV)
Time Frame: 1, 8, 24 and 72 hours after surgery
|
NRS 0-10
|
1, 8, 24 and 72 hours after surgery
|
Cumulative use of analgesics and anti-emetics
Time Frame: 1, 8, 24 and 72 hours after surgery
|
Total dose of opiates, other analgesics and anti-emetic drugs
|
1, 8, 24 and 72 hours after surgery
|
Length of hospital stay
Time Frame: From date of admission until date of discharge from the hospital (usually several days), assessed up to 3 months.
|
Total number of days from admission to discharge after surgery (not including readmission)
|
From date of admission until date of discharge from the hospital (usually several days), assessed up to 3 months.
|
Surgical conditions
Time Frame: Intraoperative: after introduction of the trocars and every 15 minutes until the end of the pneumoperitoneum.
|
Rating of the surgical conditions with the Leiden Surgical Rating Scale (L-SRS).
The L-SRS is scored by the surgeon and ranges from 1-5 for quality of the surgical field.
A score of 5 means optimal conditions: a wide laparoscopic field with no patient movements or muscle contractions, 1 means extremely poor conditions: the surgeon is unable to obtain a visible laparoscopic field because of inadequate muscle relaxation.
|
Intraoperative: after introduction of the trocars and every 15 minutes until the end of the pneumoperitoneum.
|
Intraoperative complications
Time Frame: During surgery
|
Complications during surgery graded according to the Clavien-Dindo classification
|
During surgery
|
Postoperative complications
Time Frame: Up to 3 months after surgery
|
Postoperative complications
|
Up to 3 months after surgery
|
Time to reach discharge criteria
Time Frame: From date of surgery until date of actual discharge from the hospital (usually several days), assessed up to 3 months.
|
Number of days to reach the following criteria after surgery: adequate pain control with oral medication, passage of flatus or defecation, intake of solid food tolerated, patient is mobilized and independent and patient accepts discharge.
|
From date of surgery until date of actual discharge from the hospital (usually several days), assessed up to 3 months.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Michiel C Warlé, MD, PhD, Radboud University Medical Center
- Principal Investigator: Kim I Albers, MD, Radboud University Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL65290.091.18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumoperitoneum
-
Hospital Universitario La FeInstituto de Investigacion Sanitaria La FeCompletedIndividualized Pneumoperitoneum Pressure
-
Balázs SütőActive, not recruitingPneumoperitoneum Increases Mean Expiratory Flow RateHungary
-
Karadeniz Technical UniversityUnknown
-
Kliniken Essen-MitteUnknown
-
Hannover Medical SchoolUniversity of Zurich; Technische Universität DresdenCompletedAnuria | Stress Physiology | Staff Work Load | Artificial PneumoperitoneumGermany
-
Assiut UniversityCompleted
-
National Taiwan University HospitalUnknown
-
ASST Fatebenefratelli SaccoCompletedContinuous Positive Airway Pressure [E02.041.625.790.259] | Prostatectomy [E04.950.774.860.625] | Laparoscopy [E01.370.388.250.520] | Pneumoperitoneum [C06.844.670]Italy
-
Eva IntagliataCompleted
-
University Hospital, Strasbourg, FranceCompletedPneumoperitoneumFrance
Clinical Trials on Low pressure pneumoperitoneum
-
University of JordanCompletedPain | Pneumoperitoneum | Inflammatory ResponseJordan
-
Fundacion para la Investigacion Biomedica del Hospital...Completed
-
University of JordanCompletedPain | Inflammation | PneumoperitoneumJordan
-
Pontificia Universidade Catolica de Sao PauloCompletedQuality of Life | Laparoscopic Surgery | Pneumoperitoneum | Postoperative Pain | Satisfaction, Patient | Postoperative Nausea and Vomiting | Cholecystitis; CholedocholithiasisBrazil
-
Ondokuz Mayıs UniversityCompletedLaparoscopic Nephrectomy | Cerebral Oxygen SaturationTurkey
-
Huadong HospitalRuijin HospitalUnknownProstatic Neoplasms | Urinary Bladder NeoplasmsChina
-
Radboud University Medical CenterMerck Sharp & Dohme LLCCompleted
-
Karadeniz Technical UniversityUnknown
-
University of ArizonaCompletedPneumoperitoneum | HysterectomyUnited States
-
OhioHealthCONMED CorporationTerminated